Optimal Duration of Dual Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: Lessons From Optical Coherence Tomography

Katsumasa Sato, Vasileios F. Panoulas, Toru Naganuma, Tadashi Miyazaki, Azeem Latib, Antonio Colombo

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The current case report demonstrates the interesting finding of incomplete bioresorbable vascular scaffold (BVS) strut coverage at 18 months after implantation for a chronic total occlusion of the left anterior descending coronary artery. In this case, local differences in shear stress could explain the simultaneous presence of well covered and uncovered BVS strut segments in the same optical coherence tomography frame. Even though current standard practice suggests dual antiplatelet therapy for 12 months after BVS implantation, further studies are required to establish optimal duration of dual antiplatelet therapy, particularly when tackling complex lesions.

Original languageEnglish (US)
Pages (from-to)1460.e15-1460.e17
JournalCanadian Journal of Cardiology
Volume30
Issue number11
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Optimal Duration of Dual Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: Lessons From Optical Coherence Tomography'. Together they form a unique fingerprint.

Cite this